P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .

Clinical trial NCT05008510 · WITHDRAWN

Trial details

NCT number: NCT05008510
Sponsor: Veru Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Triple Negative Breast Cancer

Start date: 2021-12-30
Primary completion: 2022-07-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.